文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

对家族性高胆固醇血症家系中儿童和青少年进行 Lp(a)升高的级联检测。

Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia.

机构信息

School of Medicine, University of Western Australia, Perth, Australia (Drs Loh, Pang, Chakraborty, Chan, Hooper, Bell, Burnett, Watts); Department of Endocrinology, Changi General Hospital, Singapore (Dr Loh); Duke-NUS Medical School, Singapore (Dr Loh).

School of Medicine, University of Western Australia, Perth, Australia (Drs Loh, Pang, Chakraborty, Chan, Hooper, Bell, Burnett, Watts).

出版信息

J Clin Lipidol. 2024 Jan-Feb;18(1):e33-e37. doi: 10.1016/j.jacl.2023.11.007. Epub 2023 Nov 17.


DOI:10.1016/j.jacl.2023.11.007
PMID:38040538
Abstract

Elevated plasma lipoprotein(a) [Lp(a)] is a common, inherited condition independently causing cardiovascular disease. Recent expert recommendations suggest opportunistically testing for elevated Lp(a) during cascade testing for familial hypercholesterolaemia (FH). We investigated the effectiveness of detecting elevated Lp(a) in 103 children and adolescents who were first-degree relatives of 66 adult index FH cases as part of an established FH cascade screening program. The yield of detection of elevated Lp(a) using a threshold of ≥30 mg/dL in children and adolescents was assessed. Cascade testing from FH index cases with elevated Lp(a) ≥50 mg/dL identified 1 case of Lp(a) ≥30 mg/dL for every 2 children or adolescents tested. In contrast, opportunistic screening from index cases with FH but normal Lp(a) levels demonstrated 1 case of Lp(a) ≥30 mg/dL for every 7.5 children or adolescents tested (p < 0.001). In conclusion, cascade testing for elevated Lp(a) from index cases with FH and elevated Lp(a) is effective in identifying new cases of elevated Lp(a).

摘要

血浆脂蛋白(a) [Lp(a)]升高是一种常见的遗传性疾病,可独立导致心血管疾病。最近的专家建议在家族性高胆固醇血症 (FH) 的级联检测中,机会性地检测升高的 Lp(a)。我们调查了在 66 例成年 FH 指数病例的一级亲属中,对 103 名儿童和青少年进行升高的 Lp(a)检测的有效性,这是既定 FH 级联筛查计划的一部分。评估了使用≥30mg/dL 阈值在儿童和青少年中检测升高的 Lp(a)的检出率。从 Lp(a)≥50mg/dL 的 FH 指数病例进行级联检测,每检测 2 名儿童或青少年即可检出 1 例 Lp(a)≥30mg/dL。相比之下,从 FH 但 Lp(a)水平正常的指数病例进行机会性筛查,每检测 7.5 名儿童或青少年即可检出 1 例 Lp(a)≥30mg/dL(p<0.001)。总之,从 Lp(a)升高的 FH 指数病例进行 Lp(a)的级联检测,可有效识别新的 Lp(a)升高病例。

相似文献

[1]
Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia.

J Clin Lipidol. 2024

[2]
Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a).

Atherosclerosis. 2022-5

[3]
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.

J Am Coll Cardiol. 2019-3-12

[4]
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group.

Atherosclerosis. 2022-5

[5]
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Eur Heart J. 2015-9-21

[6]
Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.

Atherosclerosis. 2015-3

[7]
Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.

Atherosclerosis. 2019-11-29

[8]
Cascade testing for elevated lipoprotein(a) in relatives of probands with high lipoprotein(a).

Am J Prev Cardiol. 2022-4-21

[9]
Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study.

Eur Heart J. 2023-4-21

[10]
Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.

J Med Screen. 2018-10-14

引用本文的文献

[1]
2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings.

Arch Med Sci. 2025-2-22

[2]
Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore.

Front Cardiovasc Med. 2025-2-14

[3]
Lipoprotein(a) and the atherosclerotic burden - Should we wait for clinical trial evidence before taking action?

Atheroscler Plus. 2024-9-26

[4]
Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder.

Curr Opin Lipidol. 2024-12-1

[5]
Lipoprotein(a) in Children and Adolescents: Risk or Causal Factor for Cardiovascular Disease? A Narrative Review.

Int J Mol Sci. 2024-8-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索